Matinas BioPharma Holdings, Inc. (MTNB)

CIK 1582554 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Matinas BioPharma Holdings, Inc..

Recent SEC filings

FiledFormAccession number
Sep 4, 20268-K0001493152-26-041577
Aug 25, 20264250001493152-26-039981
Aug 13, 2026SCHEDULE 13D/A0000921895-26-002111
Aug 13, 202610-Q0001493152-26-037748
Aug 13, 202640000921895-26-002105
Aug 13, 202640000921895-26-002109
Aug 4, 20264250001493152-26-036000
Jul 30, 20264250001493152-26-035330
Jul 29, 20264250001493152-26-035183
Jul 24, 20268-K0001493152-26-034601
Jul 21, 20264250001493152-26-034108
Jul 16, 20264250001493152-26-033590
Jul 14, 2026SCHEDULE 13G0001213900-26-077949
Jul 13, 20264250001493152-26-032939
Jul 13, 20268-K0001493152-26-032938
Jun 26, 20268-K0001493152-26-030342
Jun 22, 2026424B70001493152-26-029586
Jun 16, 2026S-30001493152-26-028881
May 8, 202610-Q0001493152-26-022010
Apr 3, 20268-K0001493152-26-015170
Mar 31, 202610-K0001493152-26-014132
Jan 23, 20268-K0001493152-26-003445
Dec 12, 20258-K0001493152-25-027529
Nov 21, 20258-K0001493152-25-024691
Nov 14, 2025SCHEDULE 13G/A0000902664-25-004953